Page 5 - Diagnostics Inc News Today

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now owns 96,343 shares of the company’s stock, […]

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now directly owns 96,343 shares of […]

Quest Diagnostics Inc (NYSE:DGX) recently announced a dividend of $0.75 per share, payable on 2024-04-22, with the ex-dividend date set for 2024-04-05. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Quest Diagnostics Inc's dividend performance and assess its sustainability.

/PRNewswire/ -- City of Hope, one of the largest cancer research and treatment organizations in the United States, and DELFI Diagnostics, Inc., a developer of...

Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.

Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) had its price target decreased by investment analysts at Craig Hallum from $2.00 to $1.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “hold” rating on the medical research company’s stock. Craig Hallum’s price objective suggests a potential […]

Analysts at StockNews.com assumed coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) in a report issued on Wednesday. The firm set a “hold” rating on the medical research company’s stock. Accelerate Diagnostics Trading Down 2.0 % Accelerate Diagnostics stock opened at $0.99 on Wednesday. The firm’s 50 day simple moving average is […]

Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.26) EPS for the quarter, Yahoo Finance reports. The business had revenue of $1.04 million for the quarter. Lucid Diagnostics had a negative net margin of 2,169.07% and a negative return on equity of 8,334.14%. During the same […]

/PRNewswire/ -- The "North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test...

Co-Diagnostics (NASDAQ:CODX – Get Free Report) will release its earnings data after the market closes on Thursday, March 14th. Analysts expect Co-Diagnostics to post earnings of ($0.20) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. Co-Diagnostics Price Performance CODX stock opened […]